BOTOX® Treatment in Pediatric Lower Limb Spasticity

Study Identifier
191622-111
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Statistical Analysis Plan
Available Language(s): English
Protocol
Available Language(s): English

Study Details

Medical Condition
  • Pediatrics
  • Movement Disorders - Other
  • Study Drug
  • botulinum toxin Type A
  • Normal Saline (Placebo)
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    2 - 16 Years

    Protocol Summary

    This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) in pediatric patients with lower limb spasticity.

    Study Locations

    Location
    Status
    Location
    AMS Neurology
    Pasadena, California, United States, 91106
    Status
    Not applicable
    Location
    Harrison Clinical Management
    Pomona, California, United States, 91767
    Status
    Not applicable
    Location
    Children's Hospital Colorado Dept. of PM&R
    Aurora, Colorado, United States, 80045
    Status
    Not applicable
    Location
    Associated Neurologists of Southern CT, P.C.
    Fairfield, Connecticut, United States, 06824
    Status
    Not applicable
    Location
    New England Center for Clinical Research
    Stamford, Connecticut, United States, 06905
    Status
    Not applicable
    Location
    NW FL Clinical Research Group, LLC
    Gulf Breeze, Florida, United States, 32561
    Status
    Not applicable
    Showing {first} - {last} of {total} Results